GlyTech, Inc. to Deliver a Lecture at a Seminar Held by BB-Bridge Inc.

GlyTech, Inc. (CEO: Mr. Hiroaki Asai) is scheduled to deliver a lecture at a seminar on the development of biopharmaceuticals to be held by Technical Information Institute Co. Ltd. in Tokyo on October 31st 2016.

The lecture will present a new DDS technology for biopharmaceuticals based on glycosylation as a chemical modification technology for active proteins.

• Seminar on Biopharmaceuticals Development

Last updated: October 31st, 2016

Back to index of news